Federation des caisses Desjardins du Quebec’s Tenaya Therapeutics TNYA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.3K	Buy	23,536 +9,036	+62%	+$6.67K	﹤0.01%	2156
2025 Q4	$10.3K	Hold	14,500	–	–	﹤0.01%	2245
2025 Q3	$23.5K	Buy	14,500 +6,500	+81%	+$6.55K	﹤0.01%	2009
2025 Q2	$4.89K	Buy	8,000 +3,200	+67%	+$1.63K	﹤0.01%	2259
2025 Q1	$2.74K	Hold	4,800	–	–	﹤0.01%	2284
2024 Q4	$6.86K	Buy	4,800 +3,800	+380%	+$8.52K	﹤0.01%	1995
2024 Q3	$1.93K	Buy	+1,000	New	+$2.82K	﹤0.01%	2226

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TNYA Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec increased its Tenaya Therapeutics (TNYA) stake by 62% in Q1 2026, buying an estimated $6.67K and bringing the position to 23,536 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Federation des caisses Desjardins du Quebec first reported a position in TNYA in Q3 2024 and has held it in 7 quarters since. The position peaked at $23.5K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Federation des caisses Desjardins du Quebec held 23,536 shares of Tenaya Therapeutics worth $16.3K as of Q1 2026.
Federation des caisses Desjardins du Quebec bought 9,036 Tenaya Therapeutics shares in Q1 2026, an estimated $6.67K.
Tenaya Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2156 holding.
Federation des caisses Desjardins du Quebec first reported a position in Tenaya Therapeutics in Q3 2024 and has held it in 7 quarters since.
Federation des caisses Desjardins du Quebec's Tenaya Therapeutics position peaked at $23.5K in Q3 2025.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.